This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bochenek-Klimczyk, K. Articles by Sosnowski, A. W. Search for Related Content PubMed PubMed Citation Articles by Bochenek-Klimczyk, K. Articles by Sosnowski, A. W.

Preassembled stentless valved-conduit for the replacement of the ascending aorta and aortic root

^a Department of Cardiac Surgery, Glenfield Hospital, University of Leicester, Groby Road, Leicester, LE3 9QP, UK
^b Department of Cardiovascular Sciences, Glenfield Hospital, University of Leicester, Groby Road, Leicester, LE3 9QP, UK

Corresponding author. Tel.: +44 116 2563032; fax: +44 116 2502449.

E-mail address: mg50{at}le.ac.uk (M. Galiñanes).

Here we report the early clinical results of a new preassembled stentless valved-conduit incorporating artificial sinuses of Valsalva (BioValsalva^TM). This new composite conduit incorporates a stentless porcine aortic valve (Elan, Vascutek Terumo, UK) suspended within a triple-layered vascular conduit (Triplex^TM, Vascutek Terumo, UK) constructed with sinuses of Valsalva. Between December 2006 and January 2008, 17 patients with the mean age of 65 years underwent aortic valve, root and ascending aorta replacement with the BioValsalva^TM valved-conduit. There was no perioperative mortality. There were no myocardial infarctions, cardiac failure or cerebrovascular events. Mean cardiopulmonary bypass time was 156±56 min and ischemic time was 112±33 min. Eight patients required deep hypothermic circulatory arrest for additional distal ascending aorta replacement. Mean mediastinal drainage was 499±262 ml. Postoperative transthoracic echocardiography and CT-scans of the aorta in all patients before discharge demonstrated well-functioning prosthetic aortic valves with small residual mean gradients, no regurgitation, and the presence of sinuses of Valsalva. In conclusion, the novel prefabricated, composite stentless valved-conduit BioValsalva^TM possesses excellent hemodynamic performance and can be implanted with low morbidity. In addition, the conduit material has good hemostatic properties which reduced bleeding, and is easy to implant with a variety of surgical techniques.

Key Words: Aortic valve replacement; Aortic root; Aortic operation; Valve disease